Promising new drug shows hope for fatty liver disease

NCT ID NCT05989711

First seen Jan 10, 2026 · Last updated May 12, 2026 · Updated 15 times

Summary

This study tested a new drug called pemvidutide in 212 adults with NASH, a serious fatty liver disease that can lead to liver damage. The goal was to see if the drug could reduce liver fat and scarring without making the disease worse. Participants received either the drug or a placebo, and researchers measured changes in liver health over 24 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Altimmune Clinial Study Site

    Tucson, Arizona, 85704, United States

  • Altimmune Clinical Study Site

    Chandler, Arizona, 85224, United States

  • Altimmune Clinical Study Site

    Peoria, Arizona, 85345, United States

  • Altimmune Clinical Study Site

    Tucson, Arizona, 85701, United States

  • Altimmune Clinical Study Site

    North Hollywood, California, 33019, United States

  • Altimmune Clinical Study Site

    Panorama City, California, 91402, United States

  • Altimmune Clinical Study Site

    Englewood, Colorado, 80110, United States

  • Altimmune Clinical Study Site

    Bradenton, Florida, 34201, United States

  • Altimmune Clinical Study Site

    Fort Myers, Florida, 33912, United States

  • Altimmune Clinical Study Site

    Hialeah Gardens, Florida, 33018, United States

  • Altimmune Clinical Study Site

    Miami Lakes, Florida, 33014, United States

  • Altimmune Clinical Study Site

    Port Orange, Florida, 32123, United States

  • Altimmune Clinical Study Site

    Sarasota, Florida, 34240, United States

  • Altimmune Clinical Study Site

    West Palm Beach, Florida, 33401, United States

  • Altimmune Clinical Study Site

    Dalton, Georgia, 30720, United States

  • Altimmune Clinical Study Site

    Marietta, Georgia, 30006, United States

  • Altimmune Clinical Study Site

    Bastrop, Louisiana, 78602, United States

  • Altimmune Clinical Study Site

    Shreveport, Louisiana, 71101, United States

  • Altimmune Clinical Study Site

    Clarksville, Tennessee, 37040, United States

  • Altimmune Clinical Study Site

    Germantown, Tennessee, 38138, United States

  • Altimmune Clinical Study Site

    Austin, Texas, 73301, United States

  • Altimmune Clinical Study Site

    Bellaire, Texas, 77401, United States

  • Altimmune Clinical Study Site

    Edinburg, Texas, 78539, United States

  • Altimmune Clinical Study Site

    Edinburg, Texas, 78540, United States

  • Altimmune Clinical Study Site

    Georgetown, Texas, 78626, United States

  • Altimmune Clinical Study Site

    Houston, Texas, 77036, United States

  • Altimmune Clinical Study Site

    San Antonio, Texas, 78201, United States

  • Altimmune Clinical Study Site

    San Antonio, Texas, 78204, United States

  • Altimmune Clinical Study Site

    West Jordan, Utah, 84081, United States

  • Altimmune Clinical Study Site

    San Juan, 00901, Puerto Rico

  • Austin Health

    Heidelberg, Victoria, 3084, Australia

  • Box Hill Hospital

    Box Hill, Victory, 3128, Australia

  • Fiona Stanley Hospital

    Murdoch, Western Australia, 6150, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, 5042, Australia

  • Liverpool Hospital

    Liverpool, New South Wales, 2170, Australia

  • Monash Hospital

    Clayton, Victory, 3168, Australia

  • Princess Alexandra Hospital/ Translational Research Institute

    Woolloongabba, Queensland, 4102, Australia

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, 2050, Australia

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, 6009, Australia

  • St. Vincent's Hospital Melbourne

    Fitzroy, Victoria, 3065, Australia

Conditions

Explore the condition pages connected to this study.